ConductScience.org, home

Paper8092845

In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.

Roblin PM and 2 others. Antimicrob Agents Chemother, 1994. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae. Papers, record 8092845. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8092845

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roblin PMP M
2Montalban GG
3Hammerschlag MRM R

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
Chlamydophila pneumoniaeMajor topic
FluoroquinolonesMajor topic
OfloxacinMajor topic
PiperazinesMajor topic
QuinolonesMajor topic
Microbial Sensitivity Tests

Source PubMed

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12,973,283In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/2973283PubMed
22,181,028A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.J Infect Dis1990https://conductscience.org/library/papers/2181028PubMed
32,252,040Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections.Am J Med1990https://conductscience.org/library/papers/2252040PubMed
42,010,629Infection with Chlamydia pneumoniae in Brooklyn.J Infect Dis1991https://conductscience.org/library/papers/2010629PubMed
51,571,425Persistent infection with Chlamydia pneumoniae following acute respiratory illness.Clin Infect Dis1992https://conductscience.org/library/papers/1571425PubMed
61,320,364In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1320364PubMed
71,320,366In vitro activities of five quinolones against Chlamydia pneumoniae.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1320366PubMed
88,494,377In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8494377PubMed
98,390,433The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.J Antimicrob Chemother1993https://conductscience.org/library/papers/8390433PubMed
108,215,294Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8215294PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
11,600,398In vitro and in vivo activities of sitafloxacin against Chlamydia spp.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11600398PubMed
10,553,711Activity of quinolones against Chlamydia pneumoniae.Drugs1999https://conductscience.org/library/papers/10553711PubMed
9,785,106Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.Infect Dis Obstet Gynecol1998https://conductscience.org/library/papers/9785106PubMed
9,624,507In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9624507PubMed
9,559,818In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9559818PubMed
9,303,410In vitro activity of trovafloxacin against Chlamydia pneumoniae.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9303410PubMed
8,894,585In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.Eur J Clin Microbiol Infect Dis1996https://conductscience.org/library/papers/8894585PubMed
8,549,323Antichlamydial activities of newly developed fluoroquinolones and their potential future role in the treatment of chlamydial respiratory infections.Drugs1995https://conductscience.org/library/papers/8549323PubMed
7,810,992Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7810992PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8092845

GET https://conductscience.org/api/papers/v1/8092845/authors